CSBTF OTC
Kuros Biosciences AG
1W: +0.0%
1M: -11.1%
3M: +5.6%
YTD: -37.4%
1Y: -15.2%
3Y: +1150.0%
5Y: +879.6%
$24.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$378K
-112.0% ▼
Capital Expenditures
$2M
-82.2% ▼
5Y CAGR: +55.9%
Free Cash Flow
-$2M
-218.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$69K
-101.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$10M | -$16M | -$13M | -$4M | $2M |
| Depreciation & Amort. | $3M | $3M | $3M | $3M | $3M |
| Stock-Based Comp. | $389K | $1M | $917K | $5M | $0 |
| Change in Working Capital | -$187K | -$1M | -$4M | -$3M | -$13M |
| Other Non-Cash Items | $889K | $933K | $4M | $3M | $8M |
| Operating Cash Flow | -$5M | -$7M | -$9M | $3M | -$378K |
| — Investing Activities — | |||||
| Capital Expenditures | -$374K | -$400K | -$317K | -$1M | -$2M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$9K | -$17K | $0 |
| Investing Cash Flow | -$374K | -$400K | -$326K | -$1M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$322K | -$343K | -$672K | -$604K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $6M | -$2M | $0 | $0 | -$646K |
| Financing Cash Flow | $6M | $3M | -$171K | $1M | $1M |
| Net Change in Cash | $241K | -$5M | -$10M | $4M | -$69K |
| Cash End of Period | $29M | $24M | $14M | $18M | $16M |
| Free Cash Flow | -$6M | -$8M | -$9M | $2M | -$2M |